Bausch Health, Assertio Therapeutics and Lupin have convinced a US federal judge to partially dismiss an antitrust complaint from health insurance company Humana, which accused the companies of colluding to delay the market entry of generic versions of diabetes drug Glumetza. In an order today, Judge William Alsup concluded Humana didn't prove